Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$338M |
| 2 |
Visa
V
|
+$279M |
| 3 |
Microsoft
MSFT
|
+$277M |
| 4 |
Union Pacific
UNP
|
+$277M |
| 5 |
SIVB
SVB Financial Group
SIVB
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$440M |
| 2 |
Palo Alto Networks
PANW
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$281M |
| 4 |
Cognizant
CTSH
|
+$280M |
| 5 |
CrowdStrike
CRWD
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.5% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 13.23% |
| 4 | Industrials | 11.12% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KLRS
3751
Kalaris Therapeutics
KLRS
$94.5M
| $64.4K | ﹤0.01% |
546
-7,490
| -93% | -$1.27M |
|
3752
P3 Health Partners
PIII
$41.1M
| $64.1K | ﹤0.01% |
697
+425
| +156% | +$92K |
|
3753
Latham Group
SWIM
$893M
| $62.6K | ﹤0.01% |
19,450
-1,886
| -9% | -$6.8K |
|
3754
Televisa
TV
$1.48B
| $61.9K | ﹤0.01% |
13,583
-1,618
| -11% | -$8.39K |
|
|
VLD
3755
DELISTED
Velo3D, Inc.
VLD
| $61.7K | ﹤0.01% |
985
-68
| -6% | -$6.61K |
|
|
GTHX
3756
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $60.4K | ﹤0.01% |
11,125
-101,936
| -90% | -$854K |
|
3757
BARK
BARK
$96.8M
| $59.6K | ﹤0.01% |
1,999
+1
| +0.1% | +$33 |
|
|
CTV
3758
DELISTED
Innovid Corp.
CTV
| $59.3K | ﹤0.01% |
34,674
-2,865
| -8% | -$7.76K |
|
3759
National CineMedia
NCMI
$355M
| $58.2K | ﹤0.01% |
26,463
-134
| -0.5% | -$588 |
|
|
MAPS
3760
DELISTED
WM TECHNOLOGY INC A
MAPS
| $58K | ﹤0.01% |
57,411
+23,014
| +67% | +$33.3K |
|
3761
Enel Chile
ENIC
$6.18B
| $57.6K | ﹤0.01% |
25,609
-62,073
| -71% | -$114K |
|
|
RBOT
3762
DELISTED
Vicarious Surgical
RBOT
| $57.6K | ﹤0.01% |
950
-78
| -8% | -$7.25K |
|
|
SBDS
3763
DELISTED
Solo Brands Inc
SBDS
| $57.4K | ﹤0.01% |
+386
| New | +$63.1K |
|
3764
Veritone
VERI
$139M
| $56.6K | ﹤0.01% |
10,672
-2,871
| -21% | -$18.4K |
|
|
TGAN
3765
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $56.1K | ﹤0.01% |
10,321
-881
| -8% | -$5.18K |
|
|
VXRT
3766
DELISTED
Vaxart
VXRT
| $55.9K | ﹤0.01% |
58,213
+12,448
| +27% | +$17.6K |
|
3767
Humacyte
HUMA
$191M
| $55.7K | ﹤0.01% |
26,381
+6,356
| +32% | +$19.3K |
|
|
CISO
3768
CISO Global
CISO
$11.8M
| $54.5K | ﹤0.01% |
1,426
-130
| -8% | -$5.9K |
|
3769
Outdoor Holding Co
POWW
$269M
| $53.6K | ﹤0.01% |
31,010
+34
| +0.1% | +$86 |
|
3770
Offerpad Solutions
OPAD
$23M
| $52.2K | ﹤0.01% |
756
-41
| -5% | -$4.73K |
|
3771
Torrid Holdings
CURV
$239M
| $51.8K | ﹤0.01% |
+17,504
| New | +$71.5K |
|
|
AKTS
3772
DELISTED
Akoustis Technologies Inc
AKTS
| $51.7K | ﹤0.01% |
18,318
-2,042
| -10% | -$6.42K |
|
|
AEVA
3773
Aeva Technologies
AEVA
$1.68B
| $49.7K | ﹤0.01% |
7,314
+29
| +0.4% | +$254 |
|
3774
Nerdy
NRDY
$95M
| $49.3K | ﹤0.01% |
21,908
-2,319
| -10% | -$5.04K |
|
3775
Ardelyx
ARDX
$982M
| $48.9K | ﹤0.01% |
+17,171
| New | +$29.1K |
|
Similar funds
Invesco's Q4 2022 Portfolio in Review
As of Q4 2022, Invesco held 4,129 positions worth $341B, up 9.9% from $311B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Invesco's Q4 2022 filing shows 147 new, 2,069 increased, 1,601 reduced and 115 closed positions. Its largest new stake was British American Tobacco: 3,556,143 shares worth $142M. The largest sale was UnitedHealth, an estimated $440M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q4 2022 buy was British American Tobacco: 3,556,143 shares worth $142M.
- Invesco added most to NVIDIA in Q4 2022, an estimated $338M increase.
- Invesco's biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $440M.
- Invesco fully exited Duke Realty Corp. in Q4 2022, selling an estimated $131M.
- Invesco's ten largest holdings make up 10% of its $341B portfolio in Q4 2022.
- Invesco opened 147 new positions and closed 115 in Q4 2022.
- Invesco's portfolio value rose 9.9% quarter-over-quarter to $341B.
Based on Invesco's 13F filing for Q4 2022, filed 13 Feb 2023.